These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18480918)

  • 1. Low-dose oral methotrexate induces apoptosis of tissue eosinophils in bullous pemphigoid.
    Dahlman-Ghozlan K; Ortonne JP; Bahadoran P; Spadafora A; Stephansson E
    Acta Derm Venereol; 2008; 88(3):219-22. PubMed ID: 18480918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered tissue expression pattern of cell adhesion molecules, ICAM-1, E-selectin and VCAM-1, in bullous pemphigoid during methotrexate therapy.
    Dahlman-Ghozlan K; Ortonne JP; Heilborn JD; Stephansson E
    Exp Dermatol; 2004 Feb; 13(2):65-9. PubMed ID: 15009098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dyshidrosiform bullous pemphigoid].
    Mohr C; Duschet P; Bonsmann G; Luger TA; Gschnait F; Schwarz T
    Hautarzt; 1993 Dec; 44(12):785-8. PubMed ID: 8113043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cell and eosinophil mediated damage in bullous pemphigoid.
    Goldstein SM; Wasserman SI; Wintroub BU
    Immunol Ser; 1989; 46():527-45. PubMed ID: 2484955
    [No Abstract]   [Full Text] [Related]  

  • 5. An infant with bullous pemphigoid.
    Santos AL; Mota AV; Ramon J; Lopes JM; Azevedo F
    Dermatol Online J; 2007 Jul; 13(3):17. PubMed ID: 18328211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigoid.
    Heilborn JD; Ståhle-Bäckdahl M; Albertioni F; Vassilaki I; Peterson C; Stephansson E
    J Am Acad Dermatol; 1999 May; 40(5 Pt 1):741-9. PubMed ID: 10321603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose methotrexate treatment in elderly patients with bullous pemphigoid.
    Paul MA; Jorizzo JL; Fleischer AB; White WL
    J Am Acad Dermatol; 1994 Oct; 31(4):620-5. PubMed ID: 8089289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective analysis of patients with bullous pemphigoid treated with methotrexate.
    Kjellman P; Eriksson H; Berg P
    Arch Dermatol; 2008 May; 144(5):612-6. PubMed ID: 18490587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of blood coagulation in bullous pemphigoid: role of eosinophils, and local and systemic implications.
    Marzano AV; Tedeschi A; Fanoni D; Bonanni E; Venegoni L; Berti E; Cugno M
    Br J Dermatol; 2009 Feb; 160(2):266-72. PubMed ID: 18945300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dilemma: bullous-pemphigoid-like eruption in scabies or scabies-induced bullous pemphigoid.
    Balighi K; Robati RM; Hejazi N
    Dermatol Online J; 2006 May; 12(4):13. PubMed ID: 17083868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bullous pemphigoid controlled by tetracycline.
    Thornfeldt CR; Menkes AW
    J Am Acad Dermatol; 1987 Feb; 16(2 Pt 1):305-10. PubMed ID: 3546415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathology of anti-p200 pemphigoid.
    Rose C; Weyers W; Denisjuk N; Hillen U; Zillikens D; Shimanovich I
    Am J Dermatopathol; 2007 Apr; 29(2):119-24. PubMed ID: 17414431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent immunohistochemical changes in rat cornea and retina after oral methylphenidate administration.
    Tunc E; Erdogan D; Gozil R; Bahcelioglu M; Calguner E; Take G; Caglar G; Oktem H
    Anat Histol Embryol; 2009 Apr; 38(2):128-32. PubMed ID: 19007354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary apoptosis of spiral ganglion cells induced by aminoglycoside: Fas-Fas ligand signaling pathway.
    Bae WY; Kim LS; Hur DY; Jeong SW; Kim JR
    Laryngoscope; 2008 Sep; 118(9):1659-68. PubMed ID: 18758324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical tacrolimus is a useful adjunctive therapy for bullous pemphigoid.
    Chu J; Bradley M; Marinkovich MP
    Arch Dermatol; 2003 Jun; 139(6):813-5. PubMed ID: 12810523
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bullous pemphigoid: Particular clinical and immuno-histological profil in a young woman].
    Belyamani S; Hali F; Mernissi F; Zamiati S; Bedane C; Benchikhi H
    Presse Med; 2014 Apr; 43(4 Pt 1):471-3. PubMed ID: 24440766
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of bullous pemphigoid in a patient with psoriasis and metabolic syndrome.
    Lesniewska A; Kalińska-Bienias A; Kowalewski C; Schwartz R; Wozniak K
    Cutis; 2016 Sep; 98(3):E19-E23. PubMed ID: 27814422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin Eosinophil Counts in Bullous Pemphigoid as a Prognostic Factor for Disease Severity and Treatment Response.
    Baum S; Engler Markowitz M; Lyakhovitsky A; Gershon R; Aviv H; Segal Z; Barzilai A
    Acta Derm Venereol; 2023 Jan; 103():adv00850. PubMed ID: 36250732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Activity and Apoptosis of Eosinophils in Blister Fluids, Skin and Peripheral Blood of Patients with Bullous Pemphigoid.
    Engmann J; Rüdrich U; Behrens G; Papakonstantinou E; Gehring M; Kapp A; Raap U
    Acta Derm Venereol; 2017 Apr; 97(4):464-471. PubMed ID: 27868136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bullous pemphigoid in late childhood successfully treated with mycophenolate mofetil as an adjuvant therapy.
    Fox JC; Kenkare S; Petronic-Rosic V; Soltani K; Sethi A
    Pediatr Dermatol; 2010; 27(5):537-9. PubMed ID: 20807355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.